Search ResultsShowing Results for 'tuberous sclerosis complex'
Wellness Journey with Multiple Sclerosis—Where to Start
Multiple sclerosis (MS) is a disease that affects the brain and/or the spinal cord. All patients with MS are given drug treatment. However, experts are trying to find out whether a patient’s lifestyle affect MS disease. They have looked into the effect of vitamin D, tobacco smoking, and factors that increase the risk of cardiovascular […]
Disease-modifying therapies in multiple sclerosis: Current perspectives on the latest data
Watch international experts discuss the latest data for highly effective disease-modifying therapies and changes in treatment approach for patients with multiple sclerosis.
- Describe the latest data informing the use of disease-modifying therapies in the treatment of multiple sclerosis
- Evaluate the potential benefit of early treatment with highly effective disease-modifying therapies for patients with multiple sclerosis
- Explain how patient-centric decision making can improve outcomes
Autologous Haematopoietic Cell Transplantation for Treatment-refractory Relapsing Multiple Sclerosis
Multiple sclerosis (MS) typically presents as a relapsing-remitting form (RRMS) that is characterised by neuroinflammation. Over time, this evolves into a secondary progressive form that shows more indolent inflammation but significant irreversible neurodegeneration. Maintaining this inflammatory state relies on immunologic memory and maintaining a pool of autoreactive lymphocytes.1 Many experts have hypothesised that there is […]
Highlights from the 70th Annual AAN Meeting 2018: focus on multiple sclerosis
The 70th Annual American Academy of Neurology (AAN) Meeting was held on April 21–27, 2018, in Los Angeles. This is one of the most important events in the neurology community, industry representatives presented plenty of new data on current and emerging disease-modifying therapies (DMTs) for multiple sclerosis (MS). Genentech’s presentations showcased their targeted B-cell therapy […]
Exploring The Role Of The Microbiome In Multiple Sclerosis
This article is based on the review “Exploring the Role of the Microbiome in Multiple Sclerosis” by Lloyd Kasper, Tanuja Chitnis, Mirla Avila, Nicole Sconzo, Raymond Ashton and Mark Rametta, which was published in the journal, US Neurology, 2019;15(2):82–90 DOI: https://doi.org/10.17925/USN.2019.15.2.82. Multiple sclerosis (MS) is a neurological disease of uncertain etiology, although both environmental […]
Smart devices in the management of multiple sclerosis
Multiple sclerosis (MS) is the most common autoimmune disorder affecting the central nervous system. The disease course is chronic and unpredictable, often leading to severe disability. The long-term management of the disease is challenging for patients and clinicians, and adherence to treatment is essential to maximise the long-term benefits of therapy.1 However, most immunomodulatory treatments […]
Integrating practice to enhance care of patients with multiple sclerosis
Watch leading neurologists, an imaging specialist and a patient advocate discuss the importance of integrated practice to enhance care of people with multiple sclerosis (MS).
- Assess the potential strategies for switching treatment options in patients with MS
- Appraise the imaging modalities for the assessment of disease in patients with MS
- Apply collaborative techniques with patients to improve patient satisfaction with their care
Cannabinoids and Cognition in Multiple Sclerosis
Watch this activity discussing the effects of cannabis on adult cognition, how multiple sclerosis affects cognition, and the impact of cannabis on cognition in multiple sclerosis. Gain insights into these topics with leading experts, Drs Francesca Filbey, Ralph Benedict, and Sarah Morrow.
Highlights of the EAN Congress 2018 – focus on multiple sclerosis
The 4th Congress of the European Academy of Neurology (EAN) was held from 16–19 June 2018 in Lisbon, Portugal. This article will discuss some of the key presentations on the subject of multiple sclerosis (MS), which continues to impose a substantial health and economic burden throughout Europe. In order to establish a diagnosis of MS, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!